Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Mon, 01/28/19 - 12:06 pm
Tags:
AstraZeneca
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Forbes
Mon, 01/28/19 - 11:00 am
Tags:
Big Pharma, Pfizer, Merck, AstraZeneca, Gilead Sciences, Alexion, Vertex Pharmaceuticals
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
Tue, 01/22/19 - 11:52 am
Tags:
NASH, Allergan, Regeneron, Alnylam, AstraZeneca, Merck, Takeda, Gilead Sciences, Bristol-Myers Squibb, Intercept Pharmaceuticals
Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Yahoo/Motley Fool
Sun, 01/20/19 - 03:20 pm
Tags:
drug pricing, Big Pharma, Amgen, AstraZeneca, Pfizer, GSK, Merck, Gilead
Women in Science: AstraZeneca
Pharmaforum
Sat, 01/19/19 - 06:17 pm
Tags:
women executives, women, AstraZeneca
AstraZeneca Departures Continue as Medical Chief Bohen Exits
Bloomberg
Mon, 01/14/19 - 11:05 am
Tags:
AstraZeneca, reorganization
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
Tags:
JPMHC 2019, SAGE Therapeutics, SAGE-217, Mersana, Novavax, Denali Therapeutics, AstraZeneca, Amarin, FDA, government shutdown
AstraZeneca chops 210 workers, closes sites as it looks to concentrate biologics manufacturing in one place
Endpoints
Thu, 01/10/19 - 12:16 pm
Tags:
AstraZeneca, layoffs, drug manufacturing, Colorado
AstraZeneca rejigs commercial ranks around cancer, biopharma in wake of Mallon's departure
Fierce Pharma
Tue, 01/8/19 - 09:18 am
Tags:
AstraZeneca, reorganization, oncology, restructuring
Ironwood names AstraZeneca exec as CEO; shares up 8%
Seeking Alpha
Sat, 01/5/19 - 01:41 pm
Tags:
Ironwood Pharmaceuticals, AstraZeneca, Mark Mallon
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
Tags:
breast cancer, lung cancer, AstraZeneca, Tagrisso, Novartis, Gleevec, Tasigna, Bristol-Myers Squibb, Sprycel, Pfizer, Bosulif, Takeda, Iclusig
Myriad Genetics' New FDA Nod for BRACAnalysis CDx Widens Base
Yahoo/Zacks.com
Thu, 12/20/18 - 10:16 am
Tags:
Myriad Genetics, AstraZeneca, BRACAnalysis CDx, diagnostics, Lynparza
FDA hands AstraZeneca and Merck a snap OK to market Lynparza in frontline ovarian cancer, marking a new standard in treatment
Endpoints
Thu, 12/20/18 - 10:01 am
Tags:
AstraZeneca, Merck, Lynparza, BRCA-mutated ovarian cancer, FDA
AstraZeneca mines for positives in Imfinzi's failed Mystic lung cancer trial
Fierce Pharma
Thu, 12/13/18 - 10:07 pm
Tags:
AstraZeneca, Imfinizi, clinical trials, immuno-oncology
AZ begins liver cancer immunotherapy tie-up with AVEO
Pharmaforum
Thu, 12/13/18 - 10:29 am
Tags:
AstraZeneca, Aveo Oncology, cancer immunotherapy, Imfinzi, Fotivda, hepatocellular carcinoma
AstraZeneca looks to CRISPR to boost success rates
Pharmaforum
Wed, 12/12/18 - 11:44 am
Tags:
AstraZeneca, CRISPR, drug development
AstraZeneca kicks off second blood cancer launch, this time for orphan drug Lumoxiti
Fierce Pharma
Wed, 12/12/18 - 10:05 am
Tags:
AstraZeneca, drug launches, Lumoxiti, hairy cell leukemia
AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer
Fierce Pharma
Fri, 12/7/18 - 12:09 pm
Tags:
AstraZeneca, Imfinzi, head and neck cancer, clinical trials
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
Pharmaceutical Business Review
Thu, 12/6/18 - 11:33 pm
Tags:
AstraZeneca, Covis Pharma, asthma
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca
Xconomy
Mon, 12/3/18 - 10:11 am
Tags:
GSK, M&A, Tesaro, PARP inhibitors, Zejula, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.